Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

126.56 -0.48 (-0.38%)
Streaming Delayed Price Updated: 1:34 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
51 52 Next >
News headline image
2 Healthcare Stocks to Buy in a Bear Market ↗
They can help you weather the storm. 
Via The Motley Fool
Topics Economy
News headline image
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature
As of today, January 1, 2026, Abbott Laboratories (NYSE: ABT) stands as one of the most resilient and strategically diversified giants in the global healthcare landscape. While the broader market has... 
Via PredictStreet
Topics Economy Lawsuit World Trade
News headline image
Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q3 Earnings?
Over the past six months, Abbott Laboratories’s shares (currently trading at $125.45) have posted a disappointing 7.9% loss, well below the S&P 500’s 11.2% gain. This may have investors wondering how... 
Via StockStory
Topics Stocks Supply Chain
Exact Sciences Stock Soars To 4-Year High Even As Wall Street Piles On Downgrades After Abbott Deal — Retail Traders Take Profits ↗
Via Stocktwits
Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover ↗
Via Stocktwits
News headline image
Is Fidelity Medical Equipment the Ultimate "Forever Fund" for Health Care Investors? ↗
This basket of 64 medical device stocks could raise its dividend for decades. 
Via The Motley Fool
Topics ETFs Government Supply Chain
News headline image
Broadcom Just Raised Its Dividend—But It’s Not the Only One Signaling Strength ↗
Via MarketBeat
News headline image
2 Dividend Stocks to Buy for 2026 and Beyond ↗
The healthcare sector is a great place to find quality income stocks, and these two appear to be strong picks. 
Via The Motley Fool
News headline image
1 Safe-and-Steady Stock to Consider Right Now and 2 We Turn Down
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
News headline image
Stay informed with the top movers within the S&P500 index on Monday. ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
Start the New Year Off With Passive Income: 3 Dividend Kings to Buy Now ↗
These stocks will pay you just for owning them. 
Via The Motley Fool
News headline image
My Top 10 Stocks to Buy for 2026 ↗
These players are well-positioned to potentially gain next year -- and over time. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Abbott Laboratories (NYSE:ABT) Offers a Dependable Dividend Backed by Strong Fundamentals ↗
Abbott Laboratories (ABT) is a top dividend stock with a strong history of increases, backed by exceptional earnings power and a very healthy balance sheet for reliable income. 
Via Chartmill
News headline image
Danaher Sweetens the Pot: Board Approves $0.32 Quarterly Cash Dividend, Signaling Robust Financial Health
New York, NY – December 9, 2025 – Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that its Board of Directors has approved a regular quarterly cash dividend... 
Via MarketMinute
News headline image
2 Mega-Cap Stocks with Promising Prospects and 1 Facing Challenges
"Too big to fail" is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their... 
Via StockStory
News headline image
Here's Why Grail Soared, Again, in November ↗
A combination of operational improvements and developments at its key rival bolstered the stock recently. 
Via The Motley Fool
News headline image
This Top Dividend King Just Became an Even Better Buy ↗
The healthcare leader wants to make waves in a potentially highly lucrative market. 
Via The Motley Fool
News headline image
Synlait Milk Trims 2025/2026 Milk Price Forecast Amidst Global Commodity Headwinds
New Zealand's Synlait Milk (NZX: SML) has announced a reduction in its annual base milk price forecast for the 2025/2026 season, signaling persistent challenges within the global dairy commodity... 
Via MarketMinute
Topics Economy Emissions Supply Chain
News headline image
AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy Government World Trade
News headline image
Top 2 Healthcare Stocks Every New Investor Should Know ↗
These healthcare stocks have long-term and profitable growth runways. 
Via The Motley Fool
News headline image
2 Fantastic Dividend Stocks to Buy and Hold Forever ↗
These companies have been raising their payouts for a combined 101 consecutive years. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More ↗
On a big day for tech stocks, some other less well-known companies saw even larger moves. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
Why Exact Sciences Rallied Over 50% This Week ↗
The company received a buyout offer from Abbot Labs. 
Via The Motley Fool
News headline image
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Exact Sciences Corporation (Nasdaq – EXAS)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Why Exact Sciences Stock Surged Today ↗
A healthcare giant covets the cancer screening leader's technology. 
Via The Motley Fool
News headline image
UBS Raises Medtronic Target Price Amid Strong Q2, PFA Technology Shines, But "Neutral" Stance Lingers
New York, NY – November 20, 2025 – UBS Group has adjusted its outlook on Medtronic plc (NYSE: MDT) stock, raising its price target to $102.00 from $95.00. This upward revision follows Medtronic's... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
These S&P500 stocks are gapping in today's session ↗
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Thursday. Discover the gap up and gap down stocks in the S&P500 index. 
Via Chartmill
News headline image
Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics ↗
Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highlight growth and valuation momentum. 
Via Benzinga
News headline image
Abbott To Acquire Exact Sciences For Up To $23B ↗
Under the deal, Exact Sciences shareholders will receive $105 per common share in cash. 
Via Stocktwits
News headline image
Why Exact Sciences Stock Blasted Nearly 24% Higher Today ↗
A strategic investor is reportedly in advanced talks to purchase the company. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
51 52 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.